This study investigates the safety and effects of an investigational medication in people with blood cancers such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). These are conditions where the blood and bone marrow make abnormal blood cells. The study aims to understand how the body processes the medication …
This study investigates the safety and tolerability of an investigational medication combined with other agents in people with certain blood cancers that express a protein called CD123. Hematological malignancies are types of cancer that begin in blood-forming tissue, such as the bone marrow, or in the cells of the immune …
